US Substance Abuse Treatment Market is Expected to Grow at a CAGR of 5.5% During the Forecast period (2017-2025)

Posted on 2018-07-31 by Goldstein Research in Healthcare // 0 Comments

New York, USA, 2018-Jul-31 — /EPR Network/ — According to Goldstein Research, there are over 20 million Americans over the age of 12 have an addiction, 2.6 million people with addictions have a dependence on both alcohol and illicit drugs and 6.8 million people with an addiction have a mental illness is driving the US substance abuse treatment market. US Substance Abuse Treatment Market outlook also includes technological innovations, execution strategy and investment strategies adopted by major market players and regional government in order to expand their business across the globe. Additionally, substance abuse treatment pipeline is led by cure for nicotine and alcohol addiction, with the 34 products in nicotine addiction bucket of treatment and 32 products for alcohol addiction under active development combining to produce over 50% of the total pipeline.

Browse Full Report: https://www.goldsteinresearch.com/report/us-substance-abuse-treatment-market

Market Segmentation

On the basis of our in-depth analysis, US substance abuse treatment market can be segmented as follows:

By Type Of Substance Abuse Treatment

Alcohol abuse treatment
Nicotine abuse treatment
Drug abuse treatment

“US Substance Abuse Treatment Market Outlook 2025” contains a detailed overview of the US substance abuse treatment market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by type of substance abuse treatment.

Further, for the in-depth analysis, US Substance Abuse Treatment Market Report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This market report also includes competitive outlook of some of the major players profiling of companies such as Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments. Overall, the report represents the US substance abuse treatment market trends along with the market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.

About Goldstein Research

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview. Our analysts working on Healthcare Industry Analysis reports helping various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in a rigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable for our clients’ needs and business agenda.

Matched content

Editor’s pick